Why Are Junior Researchers Outperforming Gene Editing Experts? Podcast Por  arte de portada

Why Are Junior Researchers Outperforming Gene Editing Experts?

Why Are Junior Researchers Outperforming Gene Editing Experts?

Escúchala gratis

Ver detalles del espectáculo

OFERTA POR TIEMPO LIMITADO | Obtén 3 meses por US$0.99 al mes

$14.95/mes despues- se aplican términos.

Drug development today forces patients to fit standard medications—but what if we could reverse that paradigm and design treatments tailored to each patient's unique biology?

This episode explores how specialized AI cloud infrastructure is transforming drug discovery and healthcare research–not as a distant future possibility, but as tools available to researchers today. Joining the conversation is Dr. Ilya Burkov, who shares how the right computational foundation and HPC tools accelerate scientific breakthroughs at AI speed.

The conversation reveals a significant shift in accessibility: junior researchers without specialized training now achieve 80-90% success rates in complex CRISPR experiments using agentic AI systems. These results once required years of expertise. Small research teams and startups can now access the same cutting-edge infrastructure as major pharmaceutical companies. This democratization directly impacts clinical practice: drug development timelines are compressing from decades to months, which means personalized treatments tailored to individual biology could become available within your career timeline.

It's not just about raw infrastructure efficiency. It's about the combination of technology, accessibility, domain expertise, and white-glove support that together transform what's possible in healthcare innovation.


What You Will Discover:

- Dr. Burkov: Bridging Biology and AI Infrastructure

- Nebius: AI Cloud for Drug Discovery, Genomics, Health Tech

- Scaling Personalized Patient Medicine

- Expert Support vs. Generic Clouds

- AI Success for Junior Researchers

- AI in Drug Discovery

- Nebius On Democratizing Latest GPU Access

- Future: Predicting Individual Patient Outcomes


Referenced in the show:

🖇️ "CRISPR-GPT for agentic automation of gene-editing experiments" – https://pubmed.ncbi.nlm.nih.gov/40738974/



Connect with us:

Dr. Junaid Kalia, Neurocritical Care Specialist and Founder of Savelife.AI™

💼LinkedIn - https://www.linkedin.com/in/junaidkaliamd

🔗Website - https://www.junaidkalia.com/

📹YouTube - https://www.youtube.com/@junaidkaliamd

Dr. Harvey Castro, ER Physician, #DrGPT™

💼LinkedIn - https://www.linkedin.com/in/harveycastromd/

🔗Website - https://www.harveycastromd.com/

📷Instagram - https://www.instagram.com/harveycastromd/?hl=en

Edward Marx, CEO, Advisor

💼LinkedIn - https://www.linkedin.com/in/edwardmarx/

🔗Website - https://www.marxadvisory.com/

📹YouTube - https://www.youtube.com/@EdwardMarx


Special Guest:

Dr. Ilya Burkov, Global Head of Healthcare & Lifesciences at Nebius

💼LinkedIn -

Todavía no hay opiniones